Adverse effects in patients receiving rimonabant were mostly mild and traveler. The most common for patients taking the higher 20-mg dose were disgust, which affected 12.1% of patients, dizziness, and diarrhea. Hypoglycemia incidents occurred in 5.3% of patients receiving the 20-mg dose. A body part product of patients also reported mood disturbances.
If risks and adverse effects are minimal and the base hit and efficacy profiles seen in this concentration hold up in others, the multiple-target overture beingness used with drugs like rimonabant may represent a new era in diabetes risk-factor social control, according to Richard Kahn, PhD, ADA's foreman scientific and medical seafarer. "Ideally, you want a unity drug that controls everything, and family line really are looking at to the 'poly pills' or 'poly-action' agents," Dr. Kahn says. "But of layer it is not that somebody. Rimonabant appears to be safe and well tolerated, but we need more happening with this drug, and the fact that there were some mood disturbances may be a vexation."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment